Life-saving blood cancer treatment approved for routine rollout to children and young adults on NHS
The treatment, tisagenlecleucel, sold under the brand name Kymriah, is a Car-T therapy, a personalised treatment which reprogrammes a patient's immune system cells to target the cancer